Data Knights Acquisition (DKDCA) Competitors

iSpecimen (NASDAQ:ISPC) and Data Knights Acquisition (NASDAQ:DKDCA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

Which has more risk and volatility, ISPC or DKDCA?

iSpecimen has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Comparatively, Data Knights Acquisition has a beta of 0.18, suggesting that its share price is 82% less volatile than the S&P 500.

Does the media prefer ISPC or DKDCA?

In the previous week, iSpecimen had 1 more articles in the media than Data Knights Acquisition. MarketBeat recorded 1 mentions for iSpecimen and 0 mentions for Data Knights Acquisition. Data Knights Acquisition's average media sentiment score of 0.00 equaled iSpecimen'saverage media sentiment score.

Company	Overall Sentiment
iSpecimen	Neutral
Data Knights Acquisition	Neutral

Do institutionals & insiders hold more shares of ISPC or DKDCA?

13.6% of iSpecimen shares are held by institutional investors. Comparatively, 35.3% of Data Knights Acquisition shares are held by institutional investors. 32.7% of iSpecimen shares are held by company insiders. Comparatively, 45.7% of Data Knights Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has higher earnings & valuation, ISPC or DKDCA?

Data Knights Acquisition has lower revenue, but higher earnings than iSpecimen. Data Knights Acquisition is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$9.93M	0.40	-$11.10M	-$1.23	-0.34
Data Knights Acquisition	N/A	N/A	$340K	-$0.19	-3.42

Is ISPC or DKDCA more profitable?

Data Knights Acquisition has a net margin of 0.00% compared to Data Knights Acquisition's net margin of -111.81%. iSpecimen's return on equity of 0.00% beat Data Knights Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-111.81%	-80.37%	-61.99%
Data Knights Acquisition	N/A	N/A	-5.55%

Do analysts rate ISPC or DKDCA?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Data Knights Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community prefer ISPC or DKDCA?

iSpecimen received 3 more outperform votes than Data Knights Acquisition when rated by MarketBeat users.

Company	Underperform	Outperform
iSpecimen	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%
Data Knights Acquisition	N/A	N/A

Summary

Data Knights Acquisition beats iSpecimen on 7 of the 12 factors compared between the two stocks.